Antimetastatic role of Smad4 signaling in colorectal cancer.
暂无分享,去创建一个
Yong-jig Cho | D. Gorden | Bixiang Zhang | S. Halder | P. Datta | N. Kashikar | Arunima Datta | Nilesh D. Kashikar
[1] N. Deane,et al. Smad7 induces hepatic metastasis in colorectal cancer , 2008, British Journal of Cancer.
[2] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[3] G. Giannelli,et al. Blocking transforming growth factor–beta up‐regulates E‐cadherin and reduces migration and invasion of hepatocellular carcinoma cells , 2008, Hepatology.
[4] G. Tortora,et al. LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis , 2008, Molecular Cancer Therapeutics.
[5] J. Benhattar,et al. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. , 2007, Oncology reports.
[6] K. Mohammad,et al. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. , 2007, Cancer research.
[7] M. Reiss,et al. Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo , 2006, Clinical Cancer Research.
[8] Xiu-fen Lei,et al. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. , 2006, Cancer research.
[9] K. Miyazono,et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. , 2005, Journal of the National Cancer Institute.
[10] Wei He,et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] V. Robinson,et al. Metastasis suppressor genes: From gene identification to protein function and regulation , 2005, Cancer biology & therapy.
[12] R. Beauchamp,et al. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. , 2005, Neoplasia.
[13] Jukka-Pekka Mecklin,et al. SMAD4 as a Prognostic Marker in Colorectal Cancer , 2005, Clinical Cancer Research.
[14] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[15] M. Sarris,et al. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[16] J. Massagué,et al. Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer Cells* , 1999, The Journal of Biological Chemistry.
[17] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[18] S. Al-Sedairy,et al. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. , 1993, British Journal of Cancer.
[19] G. Kaur,et al. Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression , 2008, Cancer Cell International.
[20] J. Mann,et al. Transforming Growth Factor-β (TGF-β) Signaling Inhibitors in Cancer Therapy , 2008 .
[21] M. Laiho,et al. Transforming Growth Factor-β in Cancer Therapy , 2008 .
[22] J. Behrens,et al. Cadherins and Catenins: Role in Signal Transduction and Tumor Progression , 2004, Cancer and Metastasis Reviews.
[23] R. Derynck,et al. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.
[24] J. Benhattar,et al. Loss of Smad 4 expression predicts liver metastasis in human colorectal cancer , 2022 .